11-6608113-T-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_004517.4(ILK):c.157T>A(p.Leu53Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000249 in 1,614,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars).
Frequency
Genomes: 𝑓 0.00047 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00023 ( 0 hom. )
Consequence
ILK
NM_004517.4 missense
NM_004517.4 missense
Scores
8
7
4
Clinical Significance
Conservation
PhyloP100: 3.06
Genes affected
ILK (HGNC:6040): (integrin linked kinase) This gene encodes a protein with a kinase-like domain and four ankyrin-like repeats. The encoded protein associates at the cell membrane with the cytoplasmic domain of beta integrins, where it regulates integrin-mediated signal transduction. Activity of this protein is important in the epithelial to mesenchymal transition, and over-expression of this gene is implicated in tumor growth and metastasis. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jun 2013]
TAF10 (HGNC:11543): (TATA-box binding protein associated factor 10) Initiation of transcription by RNA polymerase II requires the activities of more than 70 polypeptides. The protein that coordinates these activities is transcription factor IID (TFIID), which binds to the core promoter to position the polymerase properly, serves as the scaffold for assembly of the remainder of the transcription complex, and acts as a channel for regulatory signals. TFIID is composed of the TATA-binding protein (TBP) and a group of evolutionarily conserved proteins known as TBP-associated factors or TAFs. TAFs may participate in basal transcription, serve as coactivators, function in promoter recognition or modify general transcription factors (GTFs) to facilitate complex assembly and transcription initiation. This gene encodes one of the small subunits of TFIID that is associated with a subset of TFIID complexes. Studies with human and mammalian cells have shown that this subunit is required for transcriptional activation by the estrogen receptor, for progression through the cell cycle, and may also be required for certain cellular differentiation programs. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP4
Computational evidence support a benign effect (MetaRNN=0.10162446).
BS2
High AC in GnomAd4 at 71 AD gene.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ILK | NM_004517.4 | c.157T>A | p.Leu53Met | missense_variant | 3/13 | ENST00000299421.9 | NP_004508.1 | |
TAF10 | NM_006284.4 | c.*2809A>T | 3_prime_UTR_variant | 5/5 | ENST00000299424.9 | NP_006275.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ILK | ENST00000299421.9 | c.157T>A | p.Leu53Met | missense_variant | 3/13 | 1 | NM_004517.4 | ENSP00000299421.4 | ||
TAF10 | ENST00000299424.9 | c.*2809A>T | 3_prime_UTR_variant | 5/5 | 1 | NM_006284.4 | ENSP00000299424.4 |
Frequencies
GnomAD3 genomes AF: 0.000467 AC: 71AN: 152140Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
71
AN:
152140
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000382 AC: 96AN: 251482Hom.: 0 AF XY: 0.000383 AC XY: 52AN XY: 135918
GnomAD3 exomes
AF:
AC:
96
AN:
251482
Hom.:
AF XY:
AC XY:
52
AN XY:
135918
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000226 AC: 331AN: 1461884Hom.: 0 Cov.: 31 AF XY: 0.000224 AC XY: 163AN XY: 727246
GnomAD4 exome
AF:
AC:
331
AN:
1461884
Hom.:
Cov.:
31
AF XY:
AC XY:
163
AN XY:
727246
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000466 AC: 71AN: 152258Hom.: 0 Cov.: 32 AF XY: 0.000712 AC XY: 53AN XY: 74454
GnomAD4 genome
AF:
AC:
71
AN:
152258
Hom.:
Cov.:
32
AF XY:
AC XY:
53
AN XY:
74454
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
1
ExAC
AF:
AC:
43
Asia WGS
AF:
AC:
1
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Conflicting classifications of pathogenicity
Submissions summary: Uncertain:2Benign:2
Revision: criteria provided, conflicting classifications
LINK: link
Submissions by phenotype
not provided Uncertain:1Benign:1
Likely benign, criteria provided, single submitter | clinical testing | GeneDx | Mar 11, 2020 | This variant is associated with the following publications: (PMID: 28831623, 27662471, 27016271) - |
Uncertain significance, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Oct 22, 2017 | The p.Leu53Met variant (rs200336608) was reported in one family investigated for dilated cardiomyopathy (DCM); however this variant did not segregate with affected individuals (Begay, 2016). This variant is listed in the Genome Aggregation Database (gnomAD) with a population frequency of 0.3 percent in the European Finnish population (identified on 82 out of 25,792 chromosomes), and has been reported to the ClinVar database as a variant of uncertain significance (Variation ID: 180371). The leucine at position 53 is highly conserved considering 13 species (Alamut v2.10) and computational analyses of the p.Leu53Met variant on protein structure and function indicate a deleterious effect (SIFT: damaging, MutationTaster: disease causing, PolyPhen-2: probably damaging). Altogether, there is not enough evidence to classify the p.Leu53Met variant with certainty. - |
Primary familial hypertrophic cardiomyopathy Uncertain:1Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 22, 2025 | - - |
Uncertain significance, no assertion criteria provided | clinical testing | Blueprint Genetics | Dec 20, 2013 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Pathogenic
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Pathogenic
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T;.;T;.
Eigen
Uncertain
Eigen_PC
Uncertain
FATHMM_MKL
Uncertain
D
LIST_S2
Uncertain
.;D;.;D;D;D
M_CAP
Pathogenic
D
MetaRNN
Benign
T;T;T;T;T;T
MetaSVM
Uncertain
D
MutationAssessor
Pathogenic
H;.;H;H;H;.
PrimateAI
Pathogenic
D
PROVEAN
Benign
N;.;N;N;N;.
REVEL
Pathogenic
Sift
Pathogenic
D;.;D;D;D;.
Sift4G
Uncertain
D;D;D;D;D;D
Polyphen
D;.;D;.;D;.
Vest4
MVP
MPC
1.0
ClinPred
T
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at